Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats
Combined DPP4-I with ARNI therapy ameliorates PH and fibrosis <i>via</i> sEH suppression and EET restoration, offering a promising treatment strategy for cirrhosis-related PH.
Authors
- Junichi Hanatani (ORCID: https://orcid.org/0009-0001-9174-2477)
- Hitoshi Yoshiji (ORCID: https://orcid.org/0000-0002-5243-8544)
- Koh Kitagawa (ORCID: https://orcid.org/0000-0001-5794-1512)
- Tadashi Namisaki (ORCID: https://orcid.org/0000-0002-3158-5318)
- Shohei Asada (ORCID: https://orcid.org/0000-0001-5997-4799)
- Naoki Nishimura (ORCID: https://orcid.org/0000-0003-4727-9048)
- Akihiko Shibamoto
- Norihisa Nishimura (ORCID: https://orcid.org/0000-0002-6295-3283)
- Kosuke Kaji (ORCID: https://orcid.org/0000-0002-1822-6759)
- Masafumi Oyama (ORCID: https://orcid.org/0000-0002-4887-5522)
- Shinya Sato (ORCID: https://orcid.org/0000-0003-3049-3443)
- Tatsuya Nakatani (ORCID: https://orcid.org/0000-0003-4949-5123)
- Yuki Tsuji
Institutions
- Nara Medical University (JP)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3748/wjg.v31.i33.109562
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00